DEVELOPMENT AND INNOVATION IN CARDIOVASCULAR MEDICINE - Innovation in the Biopharmaceutical Industry - page 43

Lesions. A randomized comparison of a sirolemus-eluting stent with a standard stent
for coronary revascularization. The New England Journal of Medicine ,

346, 1773-

1780.
Murray, CJL and AD Lopez (1997). Regional patterns of disability-free life expectancy:
global burden of disease study. Lancet , 349, 1347-1352.
Rentrop, KP, H Blanke, KR Karsh and H Kreuzer (1979). Initial experience with translu-
minal recanalisation of the recently occluded infarct related coronary artery in acute
myocardial infarction: comparison with conventionally treated patients. Clinical Car-
diology , 2, 92-105.
Ringer, S (1887). Concerning the action of calcium, potassium, and sodium salts upon the
Eel's heart and upon the skeletal muscles of the frog. Journal of Physiology , 8, 15-19.
Rinkenberger, RL, EN Prystowsky, JJ Heger, PJ Troup, WM Jackman and D Zipes (1980).
Effects of intravenous and chronic oral verapamil administration in patients with
supraventricular tachyarrhythmias. Circulation , 62, 996-1010.
Rolf Smith, S, MJ Kendall, DJ Worthington and R Holder (1983). Can the biochemical
responses to a beta 2-adrenoceptor stimulant be used to assess selectivity of beta-
adrenoceptor blockers? British Journal of Clinical Pharmacology , 16, 557-560.
Ryan, TJ (2002). The coronary angiogram and its seminal contributions to cardiovascular
medicine over five decades. Circulation , 106, 752-756.
Scandinavian Simvastatin Survival Study Group (1994). Randomised trial of cholesterol
lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin
Survival Study (4S). Lancet , 344, 1383-1389.
Serruys, PW, P de Jaegere, F Kiemeneeij, C Macaya, W Rutsch, G Heyndrickx, H Emanuels-
son, J Marco, V Legrand and P Materne (1994). A comparison of balloon-expandable-
stent implantation with balloon angioplasty in patients with coronary artery disease.
Benestent Study Group. The New England Journal of Medicine , 331, 485-495.
Sever, PS, B Dahlof, NR Poulter, H Wedel, G Beevers, M Caulfield, R Collins, SE Kjeld-
sen, A Kristinsson, GT McInnes, J Mehlsen, M Nieminen, E O'Brien and J Ostergren,
for the ASCOT investigators (2003). Prevention of coronary and stroke events with
atorvastatin in hypertensive patients who have average or lower that average choles-
terol concentrations, in the Anglo-Scandinavian Cardiac Outcomes trial — Lipid low-
ering arm (ASCOT-LLA); a multicentre randomized controlled trial. Lancet , 361,

1149-1158.
Strauss, WE, T Fortin, P Hartigan, ED Folland and AF Parisi (1995). A comparison of
quality of life scores in patients with angina pectoris after angioplasty compared
with after medical therapy. Outcomes of a randomized clinical trial. Veterans Affairs
Study of Angioplasty Compared to Medical Therapy Investigators. Circulation , 92(7),
1710-1719.
Svedmyr, N (1985). Fentorol: a beta 2-adrenergic agonist for use in asthma; pharmacology,
pharmokinetics, clinical efficacy and adverse effects. Pharmacotherapy , 5, 109-126.
Tillet, WS and RL Garner (1933). The fibrinolytic activity of streptococci. Journal of Exper-
imental Medicine , 58, 485.